title: Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's disease.
abstract: BACKGROUND
  The insulin-degrading enzyme gene (IDE) is a strong functional and positional candidate for late onset Alzheimer's disease (LOAD).
  
  
  RESULTS
  We examined conserved regions of IDE and its 10 kb flanks in 269 AD cases and 252 controls thereby identifying 17 putative functional polymorphisms. These variants formed eleven haplotypes that were tagged with ten variants. Four of these showed significant association with IDE transcript levels in samples from 194 LOAD cerebella. The strongest, rs6583817, which has not previously been reported, showed unequivocal association (p = 1.5x10(-8), fold-increase = 2.12,); the eleven haplotypes were also significantly associated with transcript levels (global p = 0.003). Using an in vitro dual luciferase reporter assay, we found that rs6583817 increases reporter gene expression in Be(2)-C (p = 0.006) and HepG2 (p = 0.02) cell lines. Furthermore, using data from a recent genome-wide association study of two Croatian isolated populations (n = 1,879), we identified a proxy for rs6583817 that associated significantly with decreased plasma Abeta40 levels (ss = -0.124, p = 0.011) and total measured plasma Abeta levels (b = -0.130, p = 0.009). Finally, rs6583817 was associated with decreased risk of LOAD in 3,891 AD cases and 3,605 controls. (OR = 0.87, p = 0.03), and the eleven IDE haplotypes (global p = 0.02) also showed significant association.
  
  
  CONCLUSIONS
  Thus, a previously unreported variant unequivocally associated with increased IDE expression was also associated with reduced plasma Abeta40 and decreased LOAD susceptibility. Genetic association between LOAD and IDE has been difficult to replicate. Our findings suggest that targeted testing of expression SNPs (eSNPs) strongly associated with altered transcript levels in autopsy brain samples may be a powerful way to identify genetic associations with LOAD that would otherwise be difficult to detect.
authors.affiliation: Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, United States of America.
authors.forename: Minerva M
authors.initials: MM
authors.lastname: Carrasquillo
authors.forename: Olivia
authors.initials: O
authors.lastname: Belbin
authors.forename: Fanggeng
authors.initials: F
authors.lastname: Zou
authors.forename: Mariet
authors.initials: M
authors.lastname: Allen
authors.forename: Nilufer
authors.initials: N
authors.lastname: Ertekin-Taner
authors.forename: Morad
authors.initials: M
authors.lastname: Ansari
authors.forename: Samantha L
authors.initials: SL
authors.lastname: Wilcox
authors.forename: Mariah R
authors.initials: MR
authors.lastname: Kashino
authors.forename: Li
authors.initials: L
authors.lastname: Ma
authors.forename: Linda H
authors.initials: LH
authors.lastname: Younkin
authors.forename: Samuel G
authors.initials: SG
authors.lastname: Younkin
authors.forename: Curtis S
authors.initials: CS
authors.lastname: Younkin
authors.forename: Toros A
authors.initials: TA
authors.lastname: Dincman
authors.forename: Melissa E
authors.initials: ME
authors.lastname: Howard
authors.forename: Chanley C
authors.initials: CC
authors.lastname: Howell
authors.forename: Chloe M
authors.initials: CM
authors.lastname: Stanton
authors.forename: Christopher M
authors.initials: CM
authors.lastname: Watson
authors.forename: Michael
authors.initials: M
authors.lastname: Crump
authors.forename: Veronique
authors.initials: V
authors.lastname: Vitart
authors.forename: Caroline
authors.initials: C
authors.lastname: Hayward
authors.forename: Nicholas D
authors.initials: ND
authors.lastname: Hastie
authors.forename: Igor
authors.initials: I
authors.lastname: Rudan
authors.forename: Harry
authors.initials: H
authors.lastname: Campbell
authors.forename: Ozren
authors.initials: O
authors.lastname: Polasek
authors.forename: Kristelle
authors.initials: K
authors.lastname: Brown
authors.forename: Peter
authors.initials: P
authors.lastname: Passmore
authors.forename: David
authors.initials: D
authors.lastname: Craig
authors.forename: Bernadette
authors.initials: B
authors.lastname: McGuinness
authors.forename: Stephen
authors.initials: S
authors.lastname: Todd
authors.forename: Patrick G
authors.initials: PG
authors.lastname: Kehoe
authors.forename: David M
authors.initials: DM
authors.lastname: Mann
authors.forename: A David
authors.initials: AD
authors.lastname: Smith
authors.forename: Helen
authors.initials: H
authors.lastname: Beaumont
authors.forename: Donald
authors.initials: D
authors.lastname: Warden
authors.forename: Clive
authors.initials: C
authors.lastname: Holmes
authors.forename: Reinhard
authors.initials: R
authors.lastname: Heun
authors.forename: Heike
authors.initials: H
authors.lastname: Kölsch
authors.forename: Noor
authors.initials: N
authors.lastname: Kalsheker
authors.forename: V Shane
authors.initials: VS
authors.lastname: Pankratz
authors.forename: Dennis W
authors.initials: DW
authors.lastname: Dickson
authors.forename: Neill R
authors.initials: NR
authors.lastname: Graff-Radford
authors.forename: Ronald C
authors.initials: RC
authors.lastname: Petersen
authors.forename: Alan F
authors.initials: AF
authors.lastname: Wright
authors.forename: Steven G
authors.initials: SG
authors.lastname: Younkin
authors.forename: Kevin
authors.initials: K
authors.lastname: Morgan
mesh_terms: D000544:Alzheimer Disease / Q000201:enzymology* / Q000235:genetics; D016229:Amyloid beta-Peptides / Q000235:genetics*; D016022:Case-Control Studies; D006801:Humans; D007339:Insulysin / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics*
chemical_list: D016229:Amyloid beta-Peptides; D012333:RNA, Messenger; D007339:Insulysin